Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

PUBLICATION DATE

9 results
Display

Clinical Features of Hypersensitivity Reactions to Cisplatin and Carboplatin

Park YJ, Moon EJ, Chung HH, Roh JW, Park SY, Park YS

  • KMID: 2272046
  • Korean J Obstet Gynecol.
  • 2003 May;46(5):1018-1023.
OBJECTIVE: To characterize the clinical features of platinum compounds (cisplatin plus carboplatin) associated hypersensitivity reactions. METHODS: Medical records of 102 patients with gynecologic malignancy who received chemotherapy based on platinum at...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Selective Cytotoxicity of Novel Platinum (II) Coordination Complexes on Human Bladder Cancer Cell-Lines and Normal Kidney Cells

Kim JT, Rho YS, Jung JC

  • KMID: 2285285
  • Korean J Physiol Pharmacol.
  • 2003 Apr;7(2):111-117.
Cisplatin is often effective in cancer treatment, but its clinical use is limited because of its nephrotoxicity. We have synthesized new platinum (II) coordination complexes (PC-1 & PC-2) containing trans-l...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Lethal Effects of Radiation and Platinum Analogues on Multicellular Spheroids of HeLa Cells

Hong SE

  • KMID: 2197189
  • J Korean Soc Ther Radiol.
  • 1989 Dec;7(2):149-156.
Multicellul ar tumor spheroids of HeLa cells have been grown in a static culture system. Samples of spheroids were exposed for 2 h to graded concentration of sis-platinum and its...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Delay of the Blink Reflex in Patients Receiving Platinum-Analogue Chemotherapy

Park KY, Park YS, Park YH, Chang HJ, Cho ES, Kim SH, Kim WJ

OBJECTIVE: To investigate the presence of cranial neuropathy in patients with platinum-analogue chemotherapy using electrodiagnostic evaluations. METHODS: Thirty-nine patients whose chemotherapy was completed within a month and 40 control subjects were...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Phase II Trial of Haptaplatin/5-FU and Leucovorin for Advanced Stomach Cancer

Lee WS, Lee GW, Kim HW, Lee OJ, Lee YJ, Ko GH, Lee JS, Jang JS, Ha WS

  • KMID: 1804572
  • Cancer Res Treat.
  • 2005 Aug;37(4):208-211.
PURPOSE: Heptaplatin (SKI-2053 R) is a new platinum analogue, with a better toxicity profile than cisplatin, and has antitumor activity even in cisplatin resistant cell lines. 5-fluoruracil (5-FU) has shown...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Data Analysis for Anti-Neoplastic Chemotherapy-Related Adverse Events Reported to the Korean Pharmacovigilance Regional Network

Lee JY, Jung JW, Kang HR, Lee SH, Kim HS, Cho SH

  • KMID: 2267789
  • Korean J Med.
  • 2013 Oct;85(4):385-395.
BACKGROUND/AIMS: To describe the toxicity profile of anti-neoplastic agents from real clinical settings, we analyzed spontaneously reported adverse events (AEs) using data from the adverse drug reaction (ADR) reporting system...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Germline and somatic mutations in homologous recombination genes among Chinese ovarian cancer patients detected using next-generation sequencing

Zhao Q, Yang J, Li L, Cao D, Yu M, Shen K, the BGI Group

OBJECTIVE: To define genetic profiling of homologous recombination (HR) deficiency in Chinese ovarian cancer patients. METHODS: we have applied next-generation sequencing to detect deleterious mutations through all exons in 31 core...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Relationship between Quality of Life and Nurse-led Bedside Symptom Evaluations in Patients with Chemotherapy-induced Peripheral Neuropathy

Yoo YS, Cho OH

  • KMID: 2069893
  • Asian Nurs Res.
  • 2014 Mar;8(1):36-41.
PURPOSE: This cross-sectional study aimed at determining the relationship between patient-reported quality of life (QOL) and nurse-led bedside evaluations of chemotherapy-induced peripheral neuropathy symptoms. METHODS: One hundred ninety-five patients treated at...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Combination Chemotherapy with 5-Fluorouracil and Heptaplatin as First-line Treatment in Patients with Advanced Gastric Cancer

Min YJ, Bang SJ, Shin JW, Kim DH, Park JH, Kim GY, Ko BK, Choi DH, Cho HR

Heptaplatin is a recently developed platinum derivative. This agent has been reported to have a response rate of 17% as a single agent, and tolerable toxicity in the treatment of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr